Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial.
EClinicalMedicine. 2021 Jun;36:100926. doi: 10.1016/j.eclinm.2021.100926. Epub 2021 Jun 4.
EClinicalMedicine. 2021.
PMID: 34109306
Free PMC article.
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Ali S, Luxmi S, Anjum F, Muhaymin SM, Uddin SM, Ali A, Ali MR, Tauheed S, Khan M, Bajwa M, Baig SU, Shalim E, Ahmed I, Khan AS, Quraishy S.
Ali S, et al. Among authors: shalim e.
Trials. 2020 Nov 2;21(1):905. doi: 10.1186/s13063-020-04839-5.
Trials. 2020.
PMID: 33138867
Free PMC article.
Item in Clipboard
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma.
Ali S, Uddin SM, Ali A, Anjum F, Ali R, Shalim E, Khan M, Ahmed I, M Muhaymin S, Bukhari U, Luxmi S, Khan AS, Quraishy S.
Ali S, et al. Among authors: shalim e.
Immunotherapy. 2021 Apr;13(5):397-407. doi: 10.2217/imt-2020-0263. Epub 2021 Feb 9.
Immunotherapy. 2021.
PMID: 33557591
Free PMC article.
Item in Clipboard
Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan.
Sayeed MA, Shalim E, Farooqui F, Farman S, Khan M, Iqbal A, Ahmed I, Rajput AW, Razzaque A, Quraishy S.
Sayeed MA, et al. Among authors: shalim e.
Vaccines (Basel). 2023 Jun 30;11(7):1178. doi: 10.3390/vaccines11071178.
Vaccines (Basel). 2023.
PMID: 37514994
Free PMC article.
Item in Clipboard
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial.
Ali S, Shalim E, Farhan F, Anjum F, Ali A, Uddin SM, Shahab F, Haider M, Ahmed I, Ali MR, Khan S, Rao S, Guriro K, Elahi S, Ali M, Mushtaq T, Sayeed MA, Muhaymin SM, Luxmi S, Saifullah, Qureshi S.
Ali S, et al. Among authors: shalim e.
Trials. 2022 Nov 8;23(1):932. doi: 10.1186/s13063-022-06860-2.
Trials. 2022.
PMID: 36348476
Free PMC article.
Item in Clipboard
Cite
Cite